SA35 Disease-Free Survival as a Surrogate Endpoint for Overall Survival in Patients With Adjuvant Treatments for Completely Resected Stage I-III Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.2977
https://www.valueinhealthjournal.com/article/S1098-3015(25)05534-2/fulltext
Title :
SA35 Disease-Free Survival as a Surrogate Endpoint for Overall Survival in Patients With Adjuvant Treatments for Completely Resected Stage I-III Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)05534-2&doi=10.1016/j.jval.2025.09.2977
First page :
Section Title :
Open access? :
No
Section Order :
12494